Information de reference pour ce titreAccession Number: | 01445399-200905000-00001.
|
Author: | Vitiello, Benedetto M.D. 1*
|
Institution: | (1) National Institute of Mental Health, Bethesda, Maryland (*)Correspondence to: NIMH, Room 7147, 6001 Executive Blvd., Bethesda, MD 20892-9633, Maryland
|
Title: | TREATMENT OF ADOLESCENT DEPRESSION: WHAT WE HAVE COME TO KNOW.[Miscellaneous Article]
|
Source: | Depression and Anxiety. 26(5):393-395, May 2009.
|
References: | 1. Kessler RC, Avenevoli S, Ries Merkangas K Mood disorders in children and adolescents: an epidemiological perspective. Biol Psychiatry, 2001;49:1002-1014.
2. Weissman MM, Wolk S, Goldstein RB et al. Depressed adolescents grow up. J Am Med Assoc, 2000;281:1707-1713.
3. Weisz JR, McCarthy CA, Valeri SM Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull, 2006;132:132-149.
4. Hammad TA, Laughren T, Racoosin J Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry, 2006;63:332-339.
5. Bridge JA, Iyengar S, Salary CB et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. J Am Med Assoc, 2007;297:1683-1696.
6. TADS Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. J Am Med Assoc, 2004;292:807-820.
7. TADS Team. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry, 2007;64:1132-1144.
8. Kennard BD, Silva S, Vitiello B et al. Remission and residual symptoms after acute treatment of adolescents with major depressive disorder. J Am Acad Child Adolesc Psychiatry, 2006;45:1404-1411.
9. Vitiello B, Rohde P, Silva SG et al. Effects of treatment on level of functioning, global health, and quality of life in depressed adolescents. J Am Acad Child Adolesc Psychiatry, 2006;45:1419-1426.
10. Kennard BD, Silva SG, Tonev S et al. Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry, 2009;48:186-195.
11. Domino M, Burns BJ, Silva SG et al. The cost-effectiveness of treatments for adolescent depression: results from the TADS randomized trial. Am J Psychiatry, 2008;165:588-596.
12. Domino ME, Foster EM, Vitiello B et al. The relative cost-effectiveness of Treatments for Adolescent Depression: 36-week results from the TADS randomized trial. J Am Acad Child Adolesc Psychiatry, 2009, in press.
13. Vitiello B, Silva S, Rohde P et al. Suicidal events in the Treatment for Adolescents with Depression Study (TADS). J Clin Psychiatry, 2009, in press.
14. Goodyer I, Dubicka B, Wilkinson P et al. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomized controlled trial. Br Med J, 2007;335:142. Epub DOI: 10.1136/bmj.39224.494340.55.
15. Brent D, Emslie G, Clarke G et al. The Treatment of Adolescents with SSRI-Resistant Depression (TORDIA): a comparison of switch to venlafaxine or to another SSRI, with or without additional cognitive behavioral therapy. J Am Med Assoc, 2008;299:901-913.
16. Curry JF, Rohde P, Simons A et al. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry, 2006;45:1427-1439.
|
Language: | English.
|
Document Type: | The Cutting Edge.
|
Journal Subset: | Behavioral & Social Sciences.
|
ISSN: | 1091-4269
|
DOI Number: | https://dx.doi.org/10.1002/da.20...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|